Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,099 public trials 2,041 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Phase I Study of pCAR-19B in the Treatment of CD19-positive Relapsed/Refractory B-ALL in Children and Adolescents

NCT04888468

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +11 more
Locations: Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Completed

T-VEC in Non-melanoma Skin Cancer

NCT03458117

Conditions: Adenocarcinoma, Basal Cell Carcinoma, Carcinoma, +31 more
Locations: Department of Dermatology, University Hospital Zurich Zurich, Switzerland

View Trial Details

Completed

Study of Dasatinib to Treat Philadelphia Positive Acute Lymphoblastic Leukemia

NCT01310010

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Hospital La Fe Valencia, Spain

View Trial Details

Completed

Study to Evaluate the Safety and Efficacy of Anti-CD38 CAR-T in Relapsed or Refractory Multiple Myeloma Patients

NCT03464916

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations: Mayo Clinic Florida Jacksonville, Florida, United States

Mayo Clinic Minnesota Rochester, Minnesota, United States

Icahn School of Medicine New York, United States

University of Pennsylvania, Abramson Cancer Center Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Study of Ciforadenant in Combination With Daratumumab in Patients With Relapsed or Refractory Multiple Myeloma

NCT04280328

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

Carfilzomib and Hyper-CVAD in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoma

NCT02293109

Conditions: Contiguous Stage II Adult Lymphoblastic Lymphoma, Hematologic Diseases, Hemic and Lymphatic Diseases, +14 more
Locations: University of California Davis Sacramento, California, United States

View Trial Details

Completed

Retrospective Study to Describe Carfilzomib Use on Patients With Relapsed Multiple Myeloma in France in the Context of Carfilzomib Nominative Expanded Access and Compassionate Use

NCT04811508

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Centre Hospitalier Du Mans Le Mans, France

View Trial Details

Completed

Chiauranib in Combination With Chidamide in Patients With Relapsed/Refractory Non-Hodgkin's Lymphoma

NCT03974243

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

View Trial Details

Completed

Higher or Lower Dose Cladribine, Cytarabine, and Mitoxantrone in Treating Medically Less Fit Patients With Newly Diagnosed Acute Myeloid Leukemia or Myeloid Neoplasm

NCT03012672

Conditions: Acute Leukemia of Ambiguous Lineage, Acute Myeloid Leukemia, Hematologic Diseases, +13 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

CD19/CD20 Dual-CAR-T in B-cell Lymphoma Patients

NCT04260932

Conditions: B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Hebei Yanda Ludaopei Hospital Sanhe, Hebei, China

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions